EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
9 02-2022

EBRA releases Mapping Report: investment in European brain research still vital


9 February 2022 The EU-funded European Brain Research Area project today releases its long-awaited European Research Inventory and Mapping Report, providing insight into the brain research activities funded at the European level within the EU framework programmes FP7 and Horizon 2020, as well as the funding initiatives of the EU Joint Programme – Neurodegenerative [...]

14 12-2021

Event report | Best practices for patient safety: An EU-wide view on the use of medicines off-label


On 30 November, the GOLUP consortium held a virtual event, led by the European Brain Council, to build on the latest discussions on the Declaration on Good Off-Label Use Practices.  The event was hosted by MEP Cyrus Engerer (S&D, Malta), who is a member of the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI). [...]

8 12-2021

EBC supports European Stakeholder Group statement on maintaining the exchange of critical health data


EBC is happy to support the statement released by CPME, on behalf of the European Health Stakeholder Group, to call for a formal association of the UK to the Horizon Europe research programme. The European Health Stakeholder Group aims to raise awareness of the implications that Brexit could have for patients and the public [...]

28 10-2021

Registration open for “Best practices for patient safety: An EU-wide view on the use of medicines off-label” event on 30 November 2021


The European Brain Council is pleased to invite you to register for the digital event "Best practices for patient safety: An EU-wide view on the use of medicines off-label" to be held virtually on 30 November 2021 at 14:30 - 16:00 CET. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported by a [...]

Go to Top